Efficacy of Inactivated Influenza a Virus (H3N2) Vaccines Grown in Mammalian Cells or Embryonated Eggs

Journal of Infectious Diseases

Volumn 160, Issue 2, 1989, Pages 191-198

  Katz, Jacqueline M ^a   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; CELL CULTURE; DRUG EFFICACY; FERRET; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A; MAMMAL; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANIMAL; ANTIBODIES, VIRAL; CELL LINE; CHICK EMBRYO; CROSS REACTIONS; FEMALE; FERRETS; INFLUENZA A VIRUS; INFLUENZA VACCINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION; VACCINES, INACTIVATED; VIRUS CULTIVATION;

EID: 0024390507     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/160.2.191     Document Type: Article

References (23)

1. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44
2. Institute of Medicine. In: Division of Health Promotion and Disease Prevention, Institute of Medicine. Newvaccine development: establishing priorities. Vol I. Diseases of importance in the United States. Washington, DC: National Academy Press, 1985:359
3. Schulman JL. Immunology of influenza. In: Kilbourne ED, ed. Influenza viruses and influenza. New York: Academic Press, 1975:373-393
4. Ada GL, Jones PD. The immune response to influenza infection. Curr Top Microbiol Immunol 1986;128:1-54
5. Schild GC, Oxford JS, de Jong JC, Webster RG. Evidence for host-cell selection of influenza virus antigenic variants. Nature 1983;303:706-709
6. Robertson JS, Naeve CW, Webster RG, Bootman JS, Newman R, Schild Gc. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 1985;143:166-174
7. Robertson JS, Bootman JS, Newman R, Oxford JS, Daniels RS, Webster RG, Schild GC. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(HIN1) virus. Virology 1987;160:31-37
8. Katz JM, Naeve CW, Webster RG. Host cell-mediated variation in H3N2 influenza viruses. Virology1987;156:386-395
9. Pyhala R, pyhala L, Valle M, Aho K. Egg-grown and tissueculture- grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology. Epidemiol Infect 1987;99:745-753
10. Oxford JS, Corcoran T, Knott R, Bates J, Bartolomei O, Major D, Newman RW, Yates P, Robertson J, Webster RG, Schild GC. Serological studies with influenza A(HINl) viruses cultivated in eggs or in a canine kidney cell line (MDCK). Bull WHO 1987;65:181-187
11. Harmon MW, Rota PA, Walls HH, Kendal AP. Antibody response in humans to influenza virus type Bhost-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin MicrobioI1988;26:333-337
12. Rota PA, Shaw MW, Kendal AP. Comparison ofthe immune response to variant influenza type B hemagglutinins expressed in vaccinia virus. Virology 1987;161:269-275
13. Hartree EE Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972;48:422-427
14. Oxford JS, Corcoran T, Hugentobler AL. Quantitative analysisof the protein composition of influenza A and Bviruses using high resolution SDS polyacrylamidegels. J BioIStand1981;9:483-491
15. Potter CW, Shore SL, Mc Laren C, Stuart-Harris C. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br J Exp Pathol 1972;53:168-179
16. Potter CW, Oxford JS, Shore SL, Mc Laren C, Stuart-Harris C. Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol 1972;53:153-167
17. WHO Collaborating Centers for Reference and Research on Influenza. In: Concepts and procedures for laboratorybased influenza surveillance. Atlanta: WHO Collaborating Center for Reference and Research on Influenza, Centers for Disease Control, 1982:B-23
18. Balkovic ES, Six HR. Pulmonary and serum isotypic antibody responses of mice to live and inactivated influenza virus. Am Rev Respir Dis 1986;134:6-11
19. Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986;24:157-160
20. Eisenlohr LC, Gerhard W, Hackett CJ. Role of receptorbinding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells. J Virol 1987;61:1375-1383
21. Morrison LA, Braciale VL, Braciale TJ. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J Immunol 1988;141:363-368
22. Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS. Influenza A (HINl) vaccine efficacy in animal models is influenced by two amino acid substitutions in the haemagglutinin molecule. Virology 1989 (in press)
23. Katz JM, Webster RG. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. Virology 1988;165:446-456